Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-072639

Director acquired 1,500,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2024-06-10 Option exercise +1,500,000 6,225,641 I
Derivatives
Fairmount Funds Management LLC Director 2024-06-10 Option exercise · Series B Convertible Preferred Stock −1,500 0 I
Loading xslF345X05/ownership.xml…